Table 4 Clinical outcomes
Variables | 1–2-3 (n = 34) | 1–3-5 (n = 34) | All (n = 68) | P |
|---|---|---|---|---|
Remission status, n(%) | 0.644 | |||
CR | 14 (41.18%) | 12 (35.29%) | 26 (38.24%) | |
PR | 15 (44.12%) | 14 (41.18%) | 29 (42.65%) | |
NR | 5 (14.71%) | 8 (23.53%) | 13 (19.12%) | |
Remission time, month | 3.68 ± 1.59 | 4.42 ± 1.36 | 4.04 ± 1.52 | 0.071 |
Remission subtype, n(%) | ||||
Total remission (CR + PR) | 28 (82.35%) | 26 (76.47%) | 54 (79.41%) | 0.549 |
CR (only) | 15 (44.12%) | 12 (35.29%) | 27 (39.71%) | 0.457 |
Renal function at month 6, n(%) | ||||
Serum creatinine increasing over 50% | 0 | 0 | 0 | 1.000 |
eGFR decreasing over 25% | 1 (2.94%) | 1 (2.94%) | 2 (2.94%) | 1.000 |